Xiaohong Xue

Xiaohong Xue


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2020 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
WDWenjing Diao
Wenjing Diao
CZCaiying Zhu
Caiying Zhu
QGQisang Guo
Qisang Guo
YCYuankui Cao
Yuankui Cao
YSYu Song
Yu Song
PLPei Lu
Pei Lu
Tripartite motif‑containing (TRIM) 14 is a protein of the TRIM family. Studies have indicated that TRIM14 may be used as an oncogene in tumor cells, such as osteosarcoma, non‑small cell lung cancer and breast cancer through different pathways. However, the functions of TRIM14 in cervical cancer cells remain unclear. Therefore, this study aimed to investigate the functions of TRIM14 in cervical cancer cells and its underlying mechanism. Caski cells stably expressing TRIM14 and SiHa, and HeLa cells stably expressing TRIM14 short hairpin RNA were constructed by lentivirus‑mediated overexpression or knockdown systems. The effects of TRIM14 on proliferation and apoptosis of cervical cancer cells were detected by Cell Counting Kit‑8 (CCK‑8) assay and flow cytometry, respectively. In addition, reverse transcription‑quantitative (RT‑q) PCR and western blotting were used to investigate the expression levels of TRIM14 and of signaling pathway marker protein including P21, caspase‑3, cleaved caspase‑3, Akt and phosphorylated Akt. The results of RT‑qPCR and western blotting revealed that TRIM14 was highly expressed in human cervical cancer tissues and cell lines compared with adjacent normal tissues and normal cervical epithelial cells. TRIM14 also regulated cell proliferation and apoptosis of human SiHa, HeLa and Caski cervical cancer cell lines through the Akt signaling pathway. Additionally, TRIM14 protein levels were related to the clinical and pathological features of cervical cancer. CCK‑8 assay and flow cytometry demonstrated that TRIM14 expression could promote cervical cancer cell proliferation and autophagy suppression. Taken together, TRIM14‑induced cell proliferation and apoptosis inhibition may by evoked by the activation of the Akt pathway. This study demonstrated the role of TRIM14 in cervical cancer, and reveals its mechanism of action as a potential therapeutic target for cervical cancer.

25 September 2023 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
WDWenjing Diao
Wenjing Diao
CZCaiying Zhu
Caiying Zhu
QGQisang Guo
Qisang Guo
YCYuankui Cao
Yuankui Cao
YSYu Song
Yu Song
PLPei Lu
Pei Lu
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the GAPDH control western blotting data shown in Fig. 2B were strikingly similar to data appearing in different form in Fig. 1E in another article written by different authors at different research institutes [Liang T, Ye X, Liu Y, Qiu X, Li Z, Tian B and Yan D: FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β‑catenin. Exp Mol Med 50: 1‑12, 2018]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 22: 5145‑5154, 2020; DOI: 10.3892/mmr.2020.11634].

29 September 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
LWLu Wang
Lu Wang
ZTZhijing Tang
Zhijing Tang
HZHao Zhu
Hao Zhu
HYHailin Yu
Hailin Yu
XXXiaohong Xue
Xiaohong Xue
WZWei Zhang
Wei Zhang
Background: Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), is a prevalent endocrine disorder increasingly associated with mild cognitive impairment (MCI). Mitochondrial dysfunction and immune dysregulation may underlie this association; however, shared molecular features between these conditions remain systematically uninvestigated. Methods: We used PMOS (granulosa cell, n = 16) and MCI (peripheral blood, n = 243) to identify differentially expressed genes (DEGs) intersecting mitochondrial-related genes (MRGs), supported by enrichment and prioritized by machine-learning with cross-validation. Boxplots in PMOS and MCI confirmed directionality. Single-cell RNA sequencing (scRNA-seq) identified cell types and communication. In vitro experiments assessed SCO2, LYN, and FGR in cell lines. Results: We identified 16 mitochondrial-related genes shared by PMOS and MCI datasets. Enrichment implicated NF-κB and TNF signaling in PMOS/MCI immunometabolic features. SCO2, LYN, and FGR were upregulated across datasets, although LYN was discordant in granulosa comparison. Single-cell sequencing identified five subtypes. Pseudotime showed SCO2 and LYN upregulation in early/late stages, whereas FGR was undetectable. Secondary annotation identified plasmacytoid dendritic cells, classical monocytes, and pro-B cells; pro-B cells predominated in controls (47.5%) and classical monocytes in disease (40.5%). In vitro validation showed mRNA/protein upregulation of SCO2, LYN, and FGR in PMOS/MCI models versus control. Conclusions: This study identified SCO2, LYN, and FGR as mitochondria-associated immune-inflammatory signatures in PMOS and MCI datasets. Differential expression, feature-ranking models, pathway enrichment, transcriptional deconvolution, single-cell contextualization, and cell assessment support were utilized. Without PMOS–MCI cohorts and functional perturbation experiments, findings remain hypothesis-generating, unvalidated biomarkers or causal mechanisms.